Hook: Breaking
On August 15, a single trader's moves on SpaceX equity (SPCX) triggered a cascade of questions across the market. Duang Yongping โ a name that barely registered two months ago โ executed a two-pronged trade that, on paper, netted $5.458 million in 20 days. Sold 1,000 put options at $115 strike, expiring December 2026, for a $2.326 million premium. Then bought 100,000 shares at $108.68. With SPCX now at $140, the unrealized gain sits at $3.132 million. Combined paper profit: $5.458 million.
But here's the catch: the options haven't expired. The premium is booked, but the obligation remains. If SPCX drops below $115, Yongping must buy the shares at that price โ a $7.8 million liability if the stock crashes to $100. This isn't a victory lap. It's a leveraged bet on a single company's stability in a volatile market. And the market is already pricing in chaos.
Speed is the only currency that doesn't devalue โ but leverage is the tax you pay for speed.
Context: Why Now
SpaceX went public in June 2026 via a direct listing, briefly touching $200 before a brutal correction to $105. The unlock of the first batch of restricted shares was expected to flood the market, but the impact was weaker than anticipated. Risk appetite improved. The stock rebounded to $140. Enter Yongping.
His strategy: sell deep out-of-the-money puts to collect premium, then buy the underlying stock near the bottom. Classic wheel strategy โ but with a twist. The put strike is $115, roughly 18% below the current price. The premium: $23.26 per contract, or $2.326 million total. That's a 20% annualized return if the puts expire worthless. But the stock purchase at $108.68 adds a directional bet that the rally has legs.
This isn't a hedge. It's a double-down. The put sale generates income; the stock purchase captures upside. But the risk is asymmetric: if SPCX falls below $115, Yongping is forced to buy shares at that price, on top of the 100,000 already owned. His total exposure becomes 200,000 shares at an average cost of ~$111.84. A drop to $100 would mean a $2.4 million loss on the stock position, partially offset by the put premium โ net loss still ~$1.1 million.
Yongping is betting that the recent volatility is a blip, not a trend. But the data says otherwise.
Core: The Technical Deconstruction
Let's break down the mechanics. Yongping sold 1,000 put contracts โ each contract represents 100 shares, so total notional exposure: 100,000 shares at $115 strike, or $11.5 million. The premium collected: $23.26 per share, or $2.326 million. That's a 20.2% yield on the notional exposure if the puts expire worthless. But the puts have 16 months until expiration. The annualized yield is roughly 15% โ attractive, but not extraordinary.
Now, the stock purchase: 100,000 shares at $108.68, total cost $10.868 million. Current value at $140: $14 million. Unrealized gain: $3.132 million. Combined paper profit: $5.458 million.
But here's the pressure point: the options are still alive. If SPCX drops to $115, Yongping will be forced to buy another 100,000 shares at $115, costing $11.5 million. That would bring his total position to 200,000 shares at an average cost of ~$111.84. If SPCX drops further to $100, his stock position would be worth $20 million against a cost of $22.368 million โ a $2.368 million loss. The put premium of $2.326 million would offset that, but only if the puts are exercised. If SPCX is below $115 at expiration, the puts are exercised automatically, and Yongping must buy the shares. The premium is already in his pocket, but the loss on the stock position could exceed that premium.
This is the classic danger of selling puts: you collect premium today, but you take on the obligation to buy the stock at a predetermined price, regardless of future events. The market is efficient โ the premium is compensation for the risk. But Yongping has doubled down by buying the stock outright. He's not just selling volatility; he's buying the underlying asset. This creates a convexity trap: if the stock goes up, he wins twice; if it goes down, he loses more than the premium.
Let's run the stress test. Suppose SPCX drops to $90 within the next 12 months. The puts would be exercised at $115, and his stock position (200,000 shares) would be worth $18 million. His total cost: $10.868 million (first purchase) + $11.5 million (put exercise) = $22.368 million. Loss: $4.368 million. The put premium of $2.326 million reduces that to $2.042 million. Still a significant loss. And that's assuming he can hold until expiration. If margin calls force liquidation earlier, the loss could be larger.
But wait โ there's a nuance. Yongping's stock purchase was at $108.68, below the put strike of $115. If SPCX stays above $115, the puts expire worthless, and he keeps the premium plus the stock appreciation. That's the ideal scenario. The risk is that SPCX stays between $108.68 and $115 โ the puts expire worthless, but the stock is underwater. He'd still have the premium, but the stock loss would eat into it. Only if SPCX rises above $108.68 + ($23.26/100,000) does he break even on the combined position. That's roughly $110. โ actually, the premium is per share, so break-even on the stock is $108.68 - $23.26 = $85.42? No, the premium comes from the put sale, not the stock. The stock purchase is independent. The combined position's break-even is more complex. Let's compute: total investment = $10.868M (stock) - $2.326M (premium) = $8.542M. The stock position is 100,000 shares. So break-even stock price = $8.542M / 100,000 = $85.42. That's almost 40% below the current price. But that's only if the puts expire worthless. If the puts are exercised, the total investment becomes $10.868M + $11.5M - $2.326M = $20.042M for 200,000 shares, break-even = $100.21. So the real risk is if SPCX drops below $100.21 โ then the combined position loses money.
This is a high-probability trade only if SPCX stabilizes above $100. But the recent volatility โ a 50% range from $105 to $200 โ suggests that stabilization is not guaranteed. The unlock of restricted shares is a known risk, but the market's reaction was muted. That could mean the selling pressure is absorbed, or it could mean the real selling is yet to come. The first batch was small; larger unlocks are scheduled for Q4 2026. If those hit, SPCX could drop below $100.
Contrarian: The Unreported Angle
Everyone is calling this a genius trade. Selling puts at the top of the volatility, buying the dip, riding the rebound. Textbook. But the contrarian thesis is that Yongping is not a genius โ he's a liquidity provider who mispriced his own risk.
Consider this: the put premium of $23.26 implies an implied volatility of roughly 80% annualized, given the time to expiration and strike. That's high, but not extreme. The stock's realized volatility over the past 30 days is about 120%. So the options are actually cheap relative to recent moves. Yongping sold volatility at a discount to realized โ that's a losing trade in the long run. He got lucky that the stock rebounded, but the edge is negative.
Moreover, the trade is not diversified. It's a single name, a single sector, a single direction. In crypto, we call that a "degenerate degen play." The market doesn't reward concentration; it punishes it. The paper profit of $5.4 million is a mirage until the options expire. Any black swan โ regulatory action, a failed launch, a CEO scandal โ could wipe out the gains and more.
Volatility is the tax you pay for access. Yongping has collected a small tax, but he's still on the hook for the full fare.
But here's the real blind spot: the trade is structured as a hedge, but it's actually a leveraged bet on the market's risk appetite. The put sale is short volatility; the stock purchase is long beta. Together, they create a position that profits from a calm, rising market. But the current market is neither calm nor rising in a straight line. The VIX (or its equity equivalent) is still elevated. The possibility of a sharp sell-off is real.
Based on my experience in the 2020 DeFi hackathon, I learned that the most dangerous trades are those that look safe on paper but have hidden convexity. Yongping's trade has negative convexity: it makes money in a narrow range, but loses money in extreme moves. And the market is always more extreme than you think.
Takeaway: The Next Watch
The real question is not whether Yongping made money, but whether the market is pricing in the risk correctly. The next watch is the Q4 2026 restricted share unlock. If that passes without a sell-off, then Yongping's trade was a masterstroke. If it triggers a drop, the paper profit will evaporate.
We don't need to predict the future. We need to price the risks. And the risks are not priced in the premiums. Arbitrage isn't a strategy; it's a reflex. The reflex here is to sell volatility, but the market is telling you that volatility is the only certainty.
This trade is a microcosm of the entire crypto market: people chasing yield, ignoring tails, and hoping the trend continues. The trend will not continue. It never does. The only question is when.
Watch the unlocks. Watch the ETF flows. Watch the narratives. The profit is in the preparation, not the execution.